MX2010002633A - Composiciones para inahalacion de dheas. - Google Patents

Composiciones para inahalacion de dheas.

Info

Publication number
MX2010002633A
MX2010002633A MX2010002633A MX2010002633A MX2010002633A MX 2010002633 A MX2010002633 A MX 2010002633A MX 2010002633 A MX2010002633 A MX 2010002633A MX 2010002633 A MX2010002633 A MX 2010002633A MX 2010002633 A MX2010002633 A MX 2010002633A
Authority
MX
Mexico
Prior art keywords
dheas
inhalation compositions
compositions
present
aqueous suspension
Prior art date
Application number
MX2010002633A
Other languages
English (en)
Inventor
Manfred Keller
Ingo Friedrich
Stefan Kerscher
Original Assignee
Epigenesis Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenesis Pharmaceuticals Llc filed Critical Epigenesis Pharmaceuticals Llc
Publication of MX2010002633A publication Critical patent/MX2010002633A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

La presente invención proporciona composiciones para una suspensión acuosa que comprende DHEAS y un catión divalente. La suspensión, en combinación con un nebulizador o aerosol en bomba nasal, se puede administrar como un aerosol para el tratamiento de enfermedades y condiciones respiratorias. La presente invención también proporciona un método para la elaboración de las composiciones en forma de suspensión acuosa de la DHEA y cationes divalentes.
MX2010002633A 2007-09-07 2008-09-04 Composiciones para inahalacion de dheas. MX2010002633A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97086907P 2007-09-07 2007-09-07
PCT/US2008/075297 WO2009032955A1 (en) 2007-09-07 2008-09-04 Dheas inhalation compositions

Publications (1)

Publication Number Publication Date
MX2010002633A true MX2010002633A (es) 2010-05-20

Family

ID=40429339

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010002633A MX2010002633A (es) 2007-09-07 2008-09-04 Composiciones para inahalacion de dheas.

Country Status (10)

Country Link
US (1) US20090118249A1 (es)
EP (1) EP2197452A4 (es)
JP (1) JP2010538081A (es)
KR (1) KR20100065360A (es)
CN (1) CN101842102A (es)
AU (1) AU2008296195A1 (es)
CA (1) CA2698683A1 (es)
MX (1) MX2010002633A (es)
TW (1) TW200922600A (es)
WO (1) WO2009032955A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
JP6945614B2 (ja) * 2014-03-26 2021-10-06 オプティノーズ アズ 経鼻投与
KR102579524B1 (ko) * 2017-05-04 2023-09-18 나노로지카 에이비 폐, 비강, 설하 및/또는 인두 전달을 위해 조정된 하나 이상의 생활성 화합물로 로딩된 다공성 실리카 입자의 제조 방법
US20210353563A1 (en) * 2020-03-26 2021-11-18 Charles McDaniel Composition and method for treatment of respiratory disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055461A (en) * 1989-02-15 1991-10-08 Richardson-Vicks Inc. Anesthetic oral compositions and methods of use
IL157734A0 (en) * 2001-03-06 2004-03-28 Cellegy Pharma Inc Pharmaceutical compositions for the treatment of urogenital disorders
AU2002303427A1 (en) * 2001-04-24 2002-11-05 East Carolina University Compositions and formulations with a non-glucocorticoid steroid and/or a ubiquinone and kit for treatment of respiratory and lung disease
US20040068096A1 (en) * 2001-09-21 2004-04-08 Zenta Tsuchihashi Human single nucleotide polymorphisms in organic anion transport and multi-drug resistant proteins
US7405207B2 (en) * 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
US20050227927A1 (en) * 2004-03-31 2005-10-13 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
US8323683B2 (en) * 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
US20070053869A1 (en) * 2005-09-02 2007-03-08 Yuichi Sugiyama Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents

Also Published As

Publication number Publication date
AU2008296195A1 (en) 2009-03-12
TW200922600A (en) 2009-06-01
WO2009032955A1 (en) 2009-03-12
KR20100065360A (ko) 2010-06-16
US20090118249A1 (en) 2009-05-07
CA2698683A1 (en) 2009-03-12
EP2197452A1 (en) 2010-06-23
JP2010538081A (ja) 2010-12-09
EP2197452A4 (en) 2010-12-29
CN101842102A (zh) 2010-09-22

Similar Documents

Publication Publication Date Title
PH12017500778A1 (en) COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
EP2749284A3 (en) Combination of glycopyrronium and carmoterol
EP2046430A4 (en) ADMINISTRATION OF ANTI-THERAPY
IL205320A0 (en) Compositions comprising an electrochemically altered fluid and a therapeutic agent and use thereof for treating lung or respiratory diseases
MY153408A (en) Novel methods
WO2007082068A3 (en) Methods and compositions for treating asthma in human and non human primates
WO2008144720A3 (en) Inhibitors of igf-1r signaling for the treatment of respiratory disorders
EP2173169A4 (en) NASAL AND OPHTHALMIC DELIVERY OF AQUEOUS CORTICOSTEROID SOLUTIONS
NZ716698A (en) Patient interface
IN2014DN07611A (es)
IL183696A0 (en) Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases
MX2013013440A (es) Composiciones, metodos y sistemas para suministro respiratorio de dos o mas agentes activos.
MX354828B (es) Polvos secos de cationes metálicos monovalentes para inhalación.
EA201291306A1 (ru) Состав сухого порошка, содержащий антимускариновое средство
HK1129426A1 (zh) 用於治療肺部病症的酶的合成物
MX2015007542A (es) Nebulizador con incentivo de respiracion integrado.
MX353288B (es) Uso de levofloxacina aerosolizada para el tratamiento de fibrosis quistica.
WO2010068754A3 (en) Methods and compositions for delivery of medicaments to the lungs
MX2010002633A (es) Composiciones para inahalacion de dheas.
MX2014002465A (es) Composiciones acuosas que comprenden arbekacina.
PL2276505T3 (pl) Sprej do nosa lub krople do nosa do leczenia przeziębienia
EP2442657A4 (en) USE OF R-BAMBUTEROL AS INHALED MEDICAMENT AND COMBINATION THERAPIES FOR THE TREATMENT OF RESPIRATORY DISEASES
MY179794A (en) Compound composition for inhalation used for treating asthma
WO2011076840A3 (en) Aerosol formulation for copd
MX2010004529A (es) Composiciones de inhalacion que comprenden acido montelukast y un inhibidor de fosfodiesterasa-4 o un corticoesteroide inhalado.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal